(Q42638801)

4 November 2017

title

Temporal analysis of the rat's behavior in the plus-maze: effect of midazolam (English)

1 reference

4 November 2017

Rosa VP

1

1 reference

4 November 2017

Vandresen N

2

1 reference

4 November 2017

Calixto AV

3

1 reference

4 November 2017

Kovaleski DF

4

1 reference

4 November 2017

Faria MS

5

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

Pharmacology, Biochemistry and Behavior

4 November 2017

published in

1 reference

4 November 2017

volume

67

1 reference

4 November 2017

issue

1

1 reference

4 November 2017

page(s)

177-182

1 reference

Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety.

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

Ethopharmacological analysis of rat behavior on the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

Effects of weekly or daily exposure to the elevated plus-maze in male mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

The influence of open arm ledges and maze experience in the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

The interplay of learning and anxiety in the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

"One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

Trial 2 in the elevated plus-maze: a different form of fear?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

The use of a plus-maze to measure anxiety in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

The relation between fear induced by novel stimulation and exploratory drive

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

Anxiogenic stimuli in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900316-6

7 January 2021

10.1016/S0091-3057(00)00316-6

Identifiers

DOI

1 reference

4 November 2017

1 reference